Back

EBMT 2023 - 49th Annual Meeting of the European Group for Bone and Marrow Transplantation

Apr 23 - Apr 26, 2023 | ParisFrance

LARVOL is not affiliated with 49th Annual Meeting of the European Group for Bone and Marrow Transplantation and all trademarks, logos, and brand names are property of their respective owners

Showing 145 abstracts linked to Trials

GS02-02 - VEDOLIZUMAB FOR PROPHYLAXIS OF LOWER GASTROINTESTINAL ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION FROM UNRELATED DONORS: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY

  • Live, Symposia

NG14-02 - CONTEXT-SPECIFIC ADAPTATION, IMPLEMENTATION AND EVALUATION OF AN EHEALTH-FACILITATED INTEGRATED CARE MODEL WITH CONTINUOUS STAKEHOLDER INVOLVEMENT IN ALLOGENEIC STEM CELL TRANSPLANTATION – THE SWISS SMILE PROJECT

  • Live, Oral

NG14-03 - SIMILAR OUTCOMES BUT DIFFERENT EXPERIENCES OF GASTROSTOMY VERSUS NASOGASTRIC TUBE FEEDING IN PEDIATRIC BONE MARROW TRANSPLANT: A MIXED METHODS STUDY

  • Live, Oral

GS02-09 - EFFICACY AND SAFETY OF A SINGLE DOSE OF EXAGAMGLOGENE AUTOTEMCEL FOR TRANSFUSION-DEPENDENT Β-THALASSEMIA AND SEVERE SICKLE CELL DISEASE

  • Live, Symposia

Paed3-01 - LOW TOXICITY WITH MYELOABLATIVE CHEMO-BASED CONDITIONING FOR CHILDREN WITH ALL BELOW 4 YEARS OF AGE. RESULTS FROM THE PROSPECTIVE MULTINATIONAL FORUM-TRIAL

  • Live, Oral

Paed3-02 - UPDATED RESULTS FROM PHASE 3 STUDY TABELECLEUCEL FOR POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL OR SOLID ORGAN TRANSPLANT AFTER FAILURE RITUXIMAB(R) OR R+CHEMOTHERAPY (ALLELE)

  • Live, Oral

Paed3-05 - RUXOLITINIB IN PEDIATRIC PATIENTS WITH TREATMENT-NAÏVE OR STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE: PRIMARY FINDINGS FROM THE PHASE I/II REACH4 STUDY

  • Live, Oral

Paed4-02 - LENTIVIRAL-MEDIATED EX-VIVO GENE THERAPY FOR PEDIATRIC PATIENTS WITH SEVERE LEUKOCYTE ADHESION DEFICIENCY-I (LAD-I): INTERIM RESULTS FROM AN ONGOING PHASE 1/2 STUDY

  • Live, Oral

Paed4-06 - BIOCHEMICAL ENGRAFTMENT AND CLINICAL OUTCOMES OF EX-VIVO AUTOLOGOUS STEM CELL GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS TYPE IIIA

  • Live, Oral

LWP-2 - JIAN JIAN LUAN: ALLOGENEIC TRANSPLANTATION IN ADVANCED CUTANEOUS T-CELL LYMPHOMAS: A PROPENSITY SCORE-MATCHED CONTROLLED PROSPECTIVE TRIAL

  • Live

OS05-01 - EFFICACY AND SAFETY OF RUXOLITINIB IN PATIENTS WITH STEROID-REFECTORY CHRONIC GRAFT VERSUS HOST DISEASE AFTER CROSSOVER IN THE PHASE 3 REACH-3 STUDY

  • Live, Oral